How to buy PharmaCyte Biotech (PMCB) shares in the UK

Learn how to easily invest in PharmaCyte Biotech shares.

PharmaCyte Biotech Inc. Common Stock
- $0.06 ( - 1.94%)

PharmaCyte Biotech Inc. Common Stock (PMCB) is a leading biotechnology business based in the US. It opened the day at $3.49 after a previous close of $3.43. During the day the price has varied from a low of $3.325 to a high of $3.54. The latest price was $3.4 (25 minute delay). PharmaCyte Biotech is listed on the NASDAQ and employs 4 staff. All prices are listed in US Dollars.

How to buy shares in PharmaCyte Biotech

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: PMCB in this case.
  5. Research PharmaCyte Biotech shares. The platform should provide the latest information available.
  6. Buy your PharmaCyte Biotech shares. It's that simple.
The whole process can take as little as 15 minutes.

How has coronavirus impacted PharmaCyte Biotech's share price?

Since the stock market crash that started in February 2020, PharmaCyte Biotech's share price has had significant negative movement.

Its last market close was $3.1, which is 96.00% down on its pre-crash value of $77.5 (accounting for the 12 July 2021 split) and 1,400.00% down on the lowest point reached during the March 2020 crash when the shares fell as low as $46.5 (accounting for the 12 July 2021 split).

If you had bought $1,000 worth of PharmaCyte Biotech shares at the start of February 2020, those shares would have been worth $499.88 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $33.33.

PharmaCyte Biotech share price (NASDAQ:PMCB)

Use our graph to track the performance of PMCB stocks over time.

PharmaCyte Biotech shares at a glance

Information last updated 2021-09-03.
Previous close$3.43
Change %-0.8746%
Information last updated 2021-10-15.
52-week range$2.25 - $55.5028
50-day moving average$3.3
200-day moving average$14.0091
Dividend yieldN/A (0%)
Earnings per share (TTM)$-2.358
eToro Free Stocks

Invest in PharmaCyte Biotech shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes
Capital at risk

Fees for buying 100x PharmaCyte Biotech shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
Freetrade logo £0 No minimum £1.11
£248.46 total
Capital at risk
eToro Free Stocks logo £0 $50 £1.24
£248.59 total
Capital at risk
Fineco logo £0 No minimum £2.47
£249.82 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £0.96
£248.31 total
Capital at risk
Stake logo £0 £50 £1.53
£248.88 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £14.71
£262.06 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £11.99
£259.34 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £12.88
£260.23 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy PharmaCyte Biotech stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

PharmaCyte Biotech price performance over time

Historical closes compared with the last close of $3.4

1 week (2021-10-08) 6.58%
1 month (2021-09-16) -2.86%
3 months (2021-07-16) -74.05%
6 months (2021-04-15) -86.71%
1 year (2020-10-15) -77.62%
2 years (2019-10-15) -93.41%
3 years (2018-10-15) -96.28%
5 years (2016-10-14) -93.77%


Gross profit TTM $0
Return on assets TTM -33.45%
Return on equity TTM -61.76%
Profit margin 0%
Book value $3.544
Market capitalisation $64.4 million

TTM: trailing 12 months

How to short and sell PharmaCyte Biotech shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "PMCB.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 686,975 PharmaCyte Biotech shares held short by investors – that's known as the "short interest". This figure is 149.9% up from 274,935 last month.

There are a few different ways that this level of interest in shorting PharmaCyte Biotech shares can be evaluated.

Short interest ratio (SIR)

PharmaCyte Biotech's "short interest ratio" (SIR) is the quantity of PharmaCyte Biotech shares currently shorted divided by the average quantity of PharmaCyte Biotech shares traded daily (recently around 3.8 million). PharmaCyte Biotech's SIR currently stands at 0.18. In other words for every 100,000 PharmaCyte Biotech shares traded daily on the market, roughly 180 shares are currently held short.

However PharmaCyte Biotech's short interest can also be evaluated against the total number of PharmaCyte Biotech shares, or, against the total number of tradable PharmaCyte Biotech shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PharmaCyte Biotech's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 PharmaCyte Biotech shares in existence, roughly 30 shares are currently held short) or 0.0364% of the tradable shares (for every 100,000 tradable PharmaCyte Biotech shares, roughly 36 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against PharmaCyte Biotech.

Find out more about how you can short PharmaCyte Biotech stock.

PharmaCyte Biotech share dividends

We're not expecting PharmaCyte Biotech to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Have PharmaCyte Biotech's shares ever split?

PharmaCyte Biotech's shares were split on a 1:1550 basis on 12 July 2021. So if you had owned 1550 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your PharmaCyte Biotech shares – just the quantity. However, indirectly, the new 154900% higher share price could have impacted the market appetite for PharmaCyte Biotech shares which in turn could have impacted PharmaCyte Biotech's share price.

Share price volatility

Over the last 12 months, PharmaCyte Biotech's shares have ranged in value from as little as $2.25 up to $55.5028. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PharmaCyte Biotech's is 0.1513. This would suggest that PharmaCyte Biotech's shares are less volatile than average (for this exchange).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Shares similar to PharmaCyte Biotech

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site